Status:

COMPLETED

Urban Environmental Factors and Childhood Asthma

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborating Sponsors:

Inner-City Asthma Consortium

Rho Federal Systems Division, Inc.

Conditions:

Asthma

Allergy

Eligibility:

All Genders

Brief Summary

Minority children who grow up in poor urban neighborhoods have the highest rates of asthma, and also experience greater morbidity from acute exacerbations of this disease. The aim of this study is to ...

Detailed Description

The purpose of this study is to determine the way environmental factors (like the components of inner-city household dust) affect immune system development and symptoms of asthma in inner city childre...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Mothers:
  • Plan to give birth at the study hospital
  • Have asthma, hay fever, or eczema (or infant's father has any of these diseases)
  • Currently reside in a pre-selected area containing at least 20% of households below the U.S. government poverty level
  • At least 34 weeks pregnant at time of delivery
  • Willing to allow an umbilical cord blood specimen to be obtained from her infant
  • Willing to comply with all study requirements
  • Have access to a phone
  • Speak English. Spanish-speaking participants enrolled at sites with Spanish-speaking staff are also eligible.
  • Exclusion Criteria for Mothers:
  • HIV infected at the time of delivery
  • Plan to move out of the geographic area during the study
  • Exclusion Criteria for Infants:
  • Respiratory distress requiring intubation and ventilation for 4 hours or more
  • Respiratory distress requiring either supplemental oxygen or continuous positive airway pressure (CPAP) for 4 days or more
  • Pneumonia requiring antibiotic treatment for 1 week or more
  • Significant congenital abnormality
  • Received palivizumab for respiratory syncytial virus prophylaxis

Exclusion

    Key Trial Info

    Start Date :

    February 2 2005

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    August 31 2024

    Estimated Enrollment :

    560 Patients enrolled

    Trial Details

    Trial ID

    NCT00114881

    Start Date

    February 2 2005

    End Date

    August 31 2024

    Last Update

    July 18 2025

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Pediatric Clinical Research Unit, Johns Hopkins University

    Baltimore, Maryland, United States, 21287

    2

    Boston Medical Center

    Boston, Massachusetts, United States, 02118

    3

    Saint Louis Children's Hospital

    St Louis, Missouri, United States, 63110

    4

    Columbia University Medical Center

    New York, New York, United States, 10032